Michael L Jones - Net Worth and Insider Trading

Michael L Jones Net Worth

The estimated net worth of Michael L Jones is at least $84,088 dollars as of 2024-11-13. Michael L Jones is the Exec. Director, Finance - PAO of BioCryst Pharmaceuticals Inc and owns about 10,753 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $84,088. Details can be seen in Michael L Jones's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael L Jones has not made any transactions after 2022-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael L Jones

To

Michael L Jones Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael L Jones owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .

Click here to see the complete history of Michael L Jones’s form 4 insider trades.

Insider Ownership Summary of Michael L Jones

Ticker Comapny Transaction Date Type of Owner
BCRX BioCryst Pharmaceuticals Inc 2022-12-15 Exec Director & Finance - PAO

Michael L Jones Latest Holdings Summary

Michael L Jones currently owns a total of 1 stock. Michael L Jones owns 10,753 shares of BioCryst Pharmaceuticals Inc (BCRX) as of December 15, 2022, with a value of $84,088.

Latest Holdings of Michael L Jones

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCRX BioCryst Pharmaceuticals Inc 2022-12-15 10,753 7.82 84,088

Holding Weightings of Michael L Jones


Michael L Jones Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael L Jones has made a total of 2 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 445 shares on December 15, 2022, which brought Michael L Jones around $4,851.

Insider Trading History of Michael L Jones

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael L Jones Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael L Jones Ownership Network

Ownership Network List of Michael L Jones

No Data

Ownership Network Relation of Michael L Jones

Insider Network Chart

Michael L Jones Owned Company Details

What does BioCryst Pharmaceuticals Inc do?

Who are the key executives at BioCryst Pharmaceuticals Inc?

Michael L Jones is the Exec Director & Finance - PAO of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .

BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary

Over the past 18 months, Michael L Jones made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 8,689 shares made by Machelle Sanders , a net sale of 7,866 shares made by Nancy J Hutson , and a net purchase of 36,300 shares made by Anthony Doyle .

In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 146,748 shares.

BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioCryst Pharmaceuticals Inc Insider Transactions

No Available Data

Michael L Jones Mailing Address

Above is the net worth, insider trading, and ownership report for Michael L Jones. You might contact Michael L Jones via mailing address: 4505 Emperor Blvd., Suite 200, Durham Nc 27703.